德克斯梅德托米丁降低了成人败血症的炎症水平和道德:基于随机对照试验的系统性审查和元分析

相关实验视频

Updated: Jan 12, 2026

Cecal Ligation Puncture Procedure

Cecal Ligation Puncture Procedure

Published on: May 7, 2011

Biao Peng¹, Xuepei Huang¹, Qiting Xue¹

¹Department of Critical Care Medicine, Hunan Want Want Hospital, Changsha, China.

Frontiers in medicine

|November 6, 2025

概括

在败血症患者中,德克斯梅德托米丁可降低IL-6和TNF-α等炎症标志物. 这种治疗还显著降低了住院和28天死亡率,这表明对败血症管理的潜在益处.

科学领域:

关键护理医学关键护理医学
药理学药理学是指药理学的学科.
免疫学免疫学免疫学

背景情况:

败血症是一种危及生命的疾病,其特征是全身炎症反应.
德克斯梅德托米丁在治疗败血症及其相关炎症级联中的作用仍在调查中.
了解德克斯梅德托米丁对炎症标志物和临床结果的影响对于优化败血症治疗策略至关重要.

研究的目的:

评估德克斯梅德托米丁对败血症患者炎症状况的影响.
评估德克斯梅德托米丁对败血症临床结果的影响,包括死亡率和器官功能.
确定德克斯梅德托米丁作为败血症辅助治疗的潜在益处.

主要方法:

在PubMed,Embase和Cochrane图书馆进行了系统的文献搜索,截至2025年8月1日.
搜索包括与德克斯梅德托米丁和败血症相关的术语,重点是随机对照试验和观察性研究.
主要结局是炎症标志物 (IL-6,TNF-α,CRP),次要结局包括死亡率,ICU住院,SOFA和APACHE II分数.

主要成果:

在败血症患者中,德克斯梅德托米丁显著降低了干白素-6 (IL-6) 和瘤亡因子-α (TNF-α) 的水平.
没有观察到对C反应性蛋白 (CRP) 水平的显著影响.
用德克斯梅德托米丁治疗与住院死亡率和28天死亡率显著降低有关.

结论:

德克斯梅德托米丁在败血症中证明有效调节关键炎症性细胞因子 (IL-6,TNF-α).
德克斯梅德托米丁的使用与败血症患者的生存率的改善有关.
早期服用德克斯梅德托米丁用于镇静和抗炎作用,可能会在败血症管理中增强临床益处.

关键词:

血流感染感染感染德克斯梅德米丁 (Dexmedetomidine) 是一种制剂.这是一个元分析.镇静剂是一种镇静剂.这是一种血症.冲击冲击冲击冲击冲击冲击

更多相关视频

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model

Published on: November 6, 2020

相关概念视频

Parenteral Anesthetics: Overview

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...